Table 1_Global hotspots and trends in the application of neoadjuvant therapy for gastric cancer: a bibliometric analysis.docx

ObjectiveNeoadjuvant therapy (NAT) is increasingly being applied in gastric cancer (GC) and is recognized by international guidelines. This study aims to analyze the current status, hotspots, and research trends of NAT in GC through bibliometrics.
MethodsRelevant publications were collected from Web of Science (SCI-Expanded) and PubMed. We utilized Citespace to analyze countries, institutions, and keywords, and employed Vosviewer to examine authors and their co-cited authors, as well as journals and their co-cited journals.
ResultsThe analysis encompassed 2666 documents. The overall number of publications showed an upward trend. The top-producing countries, institutions, authors, and journals in this field were: The People’s Republic of China and Chinese Academy of Medical Sciences - Peking Union Medical College, Huang, Changming, and Annals of Surgical Oncology. The most frequently cited author and journal are Al-batran and the Journal of Clinical Oncology, respectively. Key research areas in this field include: diverse NAT strategies; open-label trials and survival outcomes; and technology empowerment. Potential future research trends encompass: deep learning applications; immune checkpoint inhibitors; nivolumab; and immunotherapy.
ConclusionWe used bibliometrics to conduct a visual analysis of the application of NAT in GC. Research hotspots include diverse NAT strategies, open-label trials and survival outcomes, and technology empowerment.